Sepsis after transrectal ultrasound (TRUS)-guided prostate biopsy is a potentially serious complication. Antibiotic prophylaxis reduces the risk of sepsis; however, practices are highly variable among urologists. Several reports show increasing incidence of bacterial resistance in patients with sepsis after TRUSguided biopsy. Preprocedure screening of high-risk patients using cultures from rectal swabs would allow targeted prophylaxis. We performed a retrospective audit of all men undergoing a TRUS-guided prostate biopsy by one of nine urologists in Newcastle, New South Wales, to assess the incidence of bacteraemia and changes in antimicrobial susceptibility
Rectal culture screening for fluoroquinolone (FQ)-resistant Enterobacteriaceae before transrectal ul...
PubMed ID: 20224265Objective: Prostate biopsy for the diagnosis of prostate cancer by transrectal ul...
AbstractAlthough the estimate of the incidence of sepsis following transrectal ultrasound-guided pro...
ABSTRACT Background Urosepsis is a rare but life-threatening complication following transrectal ul...
PURPOSE: Urosepsis is the most feared complication of transrectal prostate biopsy. The incidence may...
Introduction: There is still an ongoing debate whether a transrectal ultrasound (TRUS) approach for ...
Background: Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 mill...
Transrectal ultrasound-guided prostate biopsy (TRUSPB) is a commonly performed urological procedure....
Transrectal ultrasound-guided prostate biopsy (TRUSPB) is a commonly performed urological procedure....
AbstractBackgroundTransrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of...
Although the estimate of the incidence of sepsis following transrectal ultrasound-guided prostate bi...
Background. Fluoroquinolone-resistant infections after transrectal prostate biopsy (TRPB) are increa...
Introduction: In this study, we aimed to identify risk factors for the development of infectious com...
Infection due to prostate biopsy afflicted more than 5% of patients and is the most common reason fo...
Infection due to prostate biopsy afflicted more than 5% of patients and is the most common reason fo...
Rectal culture screening for fluoroquinolone (FQ)-resistant Enterobacteriaceae before transrectal ul...
PubMed ID: 20224265Objective: Prostate biopsy for the diagnosis of prostate cancer by transrectal ul...
AbstractAlthough the estimate of the incidence of sepsis following transrectal ultrasound-guided pro...
ABSTRACT Background Urosepsis is a rare but life-threatening complication following transrectal ul...
PURPOSE: Urosepsis is the most feared complication of transrectal prostate biopsy. The incidence may...
Introduction: There is still an ongoing debate whether a transrectal ultrasound (TRUS) approach for ...
Background: Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 mill...
Transrectal ultrasound-guided prostate biopsy (TRUSPB) is a commonly performed urological procedure....
Transrectal ultrasound-guided prostate biopsy (TRUSPB) is a commonly performed urological procedure....
AbstractBackgroundTransrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of...
Although the estimate of the incidence of sepsis following transrectal ultrasound-guided prostate bi...
Background. Fluoroquinolone-resistant infections after transrectal prostate biopsy (TRPB) are increa...
Introduction: In this study, we aimed to identify risk factors for the development of infectious com...
Infection due to prostate biopsy afflicted more than 5% of patients and is the most common reason fo...
Infection due to prostate biopsy afflicted more than 5% of patients and is the most common reason fo...
Rectal culture screening for fluoroquinolone (FQ)-resistant Enterobacteriaceae before transrectal ul...
PubMed ID: 20224265Objective: Prostate biopsy for the diagnosis of prostate cancer by transrectal ul...
AbstractAlthough the estimate of the incidence of sepsis following transrectal ultrasound-guided pro...